LAVAL, Quebec, April 24, 2014 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) and Pershing Square Capital Management L.P. ("Pershing Square") today announced that they have released the webcast replay and accompanying presentations from the April 22, 2014 investor meeting featuring Valeant Chairman and Chief Executive Officer, J. Michael Pearson and Pershing Square Chief Executive Officer, William A. Ackman, outlining Valeant's proposed acquisition of Allergan, Inc. (NYSE: AGN). The webcast and presentations can be accessed by visiting www.vpsevent.com/webcast.

About Valeant Pharmaceuticals International, Inc.
Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, eye health, neurology and branded generics. More information about Valeant can be found at www.valeant.com.

About Pershing Square
Pershing Square Capital Management, L.P. is a SEC-registered investment advisor based in New York City. 



    Contact Information:

    Valeant Pharmaceuticals:

    Investors:                 Media:

    Laurie W. Little           Renee E. Soto/Meghan Gavigan

    Valeant Pharmaceuticals
     International, Inc.       Sard Verbinnen & Co.

    949-461-6002               212-687-8080

    laurie.little@valeant.com rsoto@sardverb.com / mgavigan@sardverb.com


    Pershing Square:

    Carolyn Sargent

    Rubenstein Associates

    212-843-8030

    csargent@rubenstein.com

http://photos.prnewswire.com/prnvar/20101025/LA87217LOGO

Logo - http://photos.prnewswire.com/prnh/20101025/LA87217LOGO

SOURCE Valeant Pharmaceuticals International, Inc.